Invention Grant
- Patent Title: Peptide conjugates
-
Application No.: US16640861Application Date: 2018-08-24
-
Publication No.: US11357863B2Publication Date: 2022-06-14
- Inventor: Agamemnon Epenetos
- Applicant: ANASTASIS BIOTEC LIMITED
- Applicant Address: GB London
- Assignee: ANASTASIS BIOTEC LIMITED
- Current Assignee: ANASTASIS BIOTEC LIMITED
- Current Assignee Address: GB London
- Agency: Alston & Bird LLP
- Priority: GB1713700 20170825
- International Application: PCT/GB2018/052413 WO 20180824
- International Announcement: WO2019/038562 WO 20190228
- Main IPC: A61K47/64
- IPC: A61K47/64 ; A61K45/06 ; C07K14/47
Abstract:
The present invention provides peptide conjugates capable of translocating across the cytoplasmic membrane of a mammalian cell and inhibiting the Notch signalling pathway. Peptide conjugates, compositions and methods of the invention are useful for targeting chemo-resistant cancer stem cells.
Public/Granted literature
- US20210154310A1 PEPTIDE CONJUGATES Public/Granted day:2021-05-27
Information query
IPC分类:
